Nano FortiCore Interbody System
Spinal fusion
CommercialActive
Key Facts
About Nanovis
Nanovis is a private, commercial-stage company that has developed a proprietary nanotechnology platform for implant surface enhancement. Its flagship nanoVIS Ti™ Surface Technology is integrated into spinal interbodies and pedicle screws, with regulatory clearances and a significant commercial partnership with Medtronic. The company operates as a B2B technology provider, licensing its surface treatments to original equipment manufacturers (OEMs) in the orthopedic and spinal sectors, positioning it in the growing market for advanced biomaterials.
View full company profileTherapeutic Areas
Other Spinal fusion Drugs
| Drug | Company | Phase |
|---|---|---|
| JAZBI™ Cubes | SDIP Innovations | Preclinical |
| Expandable Interbody Portfolio | Globus Medical | Iterative Development |
| Mimetic Metal Technology Development | CoreLink Surgical | Development/Commercial |
| Bone Graft Substitute | BiologicsMD | Pre-clinical |
| VisuALIF | SpineSmith | Commercial |
| ASTRO Registry | Artoss | Post-Market |
| Hive Smart Implant Exploration | NanoHive Medical | Pre-clinical R&D |
| ProLift Pivot Expandable Spacer System | Life Spine | FDA Cleared |
| NEXXT MATRIXX Clinical Evidence Study | Nexxt Spine | Post-Market Study |
| AGA111 | Angitia Biopharmaceuticals | Phase 3 |
| X-PAC® Portfolio Expansion | Expanding Innovations | Development |
| SOLACE™ | Xenix Medical | Commercial |